GreenLab, an emerging next generation plant-biotechnology company producing complex proteins in corn, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. Together, GreenLab and Ginkgo aim to enable production of brazzein, a sweet-tasting protein found in the fruit of the native West African Oubli plant, at commercial scale. The two companies have previously partnered on a project to develop an enzyme for GreenLab's PFAS degradation application. Read More
GreenLab, an emerging next generation plant-biotechnology company producing complex proteins in corn, today announced a new partnership with Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity. GreenLab is developing a product with the purpose of degrading PFAS and will leverage Ginkgo Enzyme Services to discover a novel enzyme of critical importance for use in this application. Read More
Statements by Dr. Elizabeth E. Hood, Founder and Director of Research and Development and Karen B. Wilson, Co-Founder and Director of Corporate Development, GreenLab, Inc. Read More
GreenLab, Inc. names Ryan Schon as its new Chief Operating Officer. Schon will help lead execution of the launch strategy of the company’s GreenLab Vector Technology (GVT) platform introduced by the biotech startup earlier this year. Read More
GreenLab, Inc. announces launch of the biotech startup’s proprietary vector technology platform. GreenLab Vector Technology (GVT) greens recombinant protein manufacturing by transforming novel proteins into highly scalable corn multiplied exponentially across acres of cornfields. Read More
GreenLab, Inc. announces closing a $5,268,944.44 seed funding round. The group of investors from Northeast Arkansas represents a cross section of the agricultural industry who understand the critical role of sustainability and value of optimizing proteins. Read More
